Lymphocyte cytosolic protein 2 is a novel prognostic marker in lung adenocarcinoma
Objective Lymphocyte cytosolic protein 2 (LCP2) is often ectopically expressed in various human tumors. However, the clinical significance and role of LCP2 in lung adenocarcinoma (LUAD) remain unclear. This study explored the prognostic significance of LCP2 in LUAD patients. Methods LCP2 expression...
Enregistré dans:
Auteurs principaux: | Yishan Huo, Kainan Zhang, Songtao Han, Yangchun Feng, Yongxing Bao |
---|---|
Format: | article |
Langue: | EN |
Publié: |
SAGE Publishing
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/aa5f3f99e38743f5b809e213ecae1d1a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Zc3h12d, a Novel of Hypomethylated and Immune-Related for Prognostic Marker of Lung Adenocarcinoma
par: Yang B, et autres
Publié: (2021) -
Clinicopathological and prognostic implications of ALK rearrangement in patients with completely surgically resected lung adenocarcinoma
par: Huan Zhang, et autres
Publié: (2021) -
A novel prognostic signature of immune-related lncRNA pairs in lung adenocarcinoma
par: Yang Liu, et autres
Publié: (2021) -
Diagnostic and prognostic potential of the oral and gut microbiome for lung adenocarcinoma
par: Mi Young Lim, et autres
Publié: (2021) -
GPI Is a Prognostic Biomarker and Correlates With Immune Infiltrates in Lung Adenocarcinoma
par: Jiahui Han, et autres
Publié: (2021)